JCIC Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $31.7K | Buy |
520
+180
| +53% | +$11K | 0.01% | 81 |
|
|
2024
Q4 | $19.2K | Hold |
340
| – | – | 0.01% | 83 |
|
|
2024
Q3 | $17.6K | Hold |
340
| – | – | 0.01% | 84 |
|
|
2024
Q2 | $14.1K | Hold |
340
| – | – | 0.01% | 90 |
|
|
2024
Q1 | $18.4K | Hold |
340
| – | – | 0.01% | 89 |
|
|
2023
Q4 | $17.4K | Sell |
340
-600
| -64% | -$30.8K | 0.01% | 91 |
|
|
2023
Q3 | $54.6K | Hold |
940
| – | – | 0.03% | 64 |
|
|
2023
Q2 | $60.1K | Hold |
940
| – | – | 0.03% | 66 |
|
|
2023
Q1 | $65.2K | Hold |
940
| – | – | 0.03% | 59 |
|
|
2022
Q4 | $68K | Hold |
940
| – | – | 0.03% | 61 |
|
|
2022
Q3 | $73K | Sell |
940
-789
| -46% | -$61.3K | 0.03% | 60 |
|
|
2022
Q2 | $133K | Hold |
1,729
| – | – | 0.07% | 49 |
|
|
2022
Q1 | $126K | Buy |
1,729
+600
| +53% | +$43.7K | 0.04% | 64 |
|
|
2021
Q4 | $70K | Sell |
1,129
-730
| -39% | -$45.3K | 0.02% | 74 |
|
|
2021
Q3 | $110K | Hold |
1,859
| – | – | 0.04% | 65 |
|
|
2021
Q2 | $154K | Hold |
1,859
| – | – | 0.04% | 67 |
|
|
2021
Q1 | $117K | Buy |
1,859
+340
| +22% | +$21.4K | 0.04% | 64 |
|
|
2020
Q4 | $94K | Buy |
1,519
+789
| +108% | +$48.8K | 0.04% | 63 |
|
|
2020
Q3 | $44K | Buy |
730
+110
| +18% | +$6.63K | 0.02% | 68 |
|
|
2020
Q2 | $36K | Buy |
620
+170
| +38% | +$9.87K | 0.02% | 67 |
|
|
2020
Q1 | $25K | Buy |
+450
| New | +$25K | 0.02% | 68 |
|